Rohto Pharmaceutical Co.,Ltd.
4527
Rangering i aksjer
#3853
Established in Osaka, Japan, in 1899, Rohto Pharmaceutical Co.,Ltd. is a global... Established in Osaka, Japan, in 1899, Rohto Pharmaceutical Co.,Ltd. is a global entity engaged in the development, manufacturing, and marketing of a diverse array of pharmaceutical goods, beauty products, and nutritional supplements. Their comprehensive product line includes various ophthalmic solutions such as eye drops, contact lens care products, and eye washes. For skincare, they offer facial treatments like cleansers, toners, and creams, in addition to specialized medicated preparations for the skin. The company's offerings also extend to internal medicines, encompassing digestive aids, herbal remedies, and dietary supplements. Furthermore, they supply over-the-counter medications and deliver beauty and health services via dedicated counters. The company rebranded from Yamada Pharmaceutical to Rohto Pharmaceutical Co.,Ltd. in September 1949.
Aksjekurs
$19.13
Markedsverdi
$4.32B
Endring (1 dag)
0.67%
Endring (1 år)
16.94%
Land
JP
Handel Rohto Pharmaceutical Co.,Ltd. (4527)
Kategori
Consumer Defensive
P/B-forhold for Rohto Pharmaceutical Co.,Ltd. (4527)
P/B-forhold per October 2026 TTM: 2.12
Ifølge Rohto Pharmaceutical Co.,Ltd. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 2.12. Ved slutten av 2024 hadde selskapet et P/B-forhold på 2.78.
P/B-historikk for Rohto Pharmaceutical Co.,Ltd. fra 2008 til 2026
P/B-forhold ved hvert års slutt
| År | P/B-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 2.12 | 8.14% |
| 2025 | 1.96 | -29.60% |
| 2024 | 2.78 | -7.74% |
| 2023 | 3.02 | 27.55% |
| 2022 | 2.36 | 9.42% |
| 2021 | 2.16 | -10.85% |
| 2020 | 2.42 | -2.28% |
| 2019 | 2.48 | -6.56% |
| 2018 | 2.65 | 31.90% |
| 2017 | 2.01 | -4.31% |
| 2016 | 2.10 | 19.43% |
| 2015 | 1.76 | -17.86% |
| 2014 | 2.14 | 39.31% |
| 2013 | 1.54 | 7.21% |
| 2012 | 1.44 | 8.85% |
| 2011 | 1.32 | -18.47% |
| 2010 | 1.62 | 4.50% |
| 2009 | 1.55 | -24.79% |
| 2008 | 2.06 | 0.00% |
P/B-forhold for lignende selskaper eller konkurrenter
| Selskap | P/B-forhold | Forskjell i P/B-forhold | Land |
|---|---|---|---|
| 6.9837 | 229.50% |
US
|
|
| 6.3772 | 200.88% |
FR
|
|
| 313.1528 | 14,674.84% |
US
|
|
| 9.0934 | 329.04% |
IN
|
|
| 9.6919 | 357.27% |
US
|
